Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty



Status:Recruiting
Conditions:Arthritis, Osteoarthritis (OA)
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:18 - 100
Updated:11/10/2018
Start Date:November 13, 2017
End Date:December 2019
Contact:Afshin Anoushiravani
Email:Afshin.Anoushiravani@nyumc.org
Phone:212 598 6146

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to determine whether an occlusive antimicrobial barrier dressing
or portable negative pressure wound dressing is superior in preventing wound complications
and infection rates in obese patients undergoing total joint arthroplasty (TJA).
Approximately 240 subjects (120 for total knee arthroplasty and 120 for total hip
arthroplasty) will be enrolled to evaluate the outcomes associated with silver impregnated
dressings and negative pressure wound therapy (NPWT) in treating this subset of patients and
analyze the cost benefit of each.


Inclusion Criteria:

- Those identified at pre-operative testing to have an elevated BMI (> 35)

Exclusion Criteria:

- Active infection

- previous scar or wound healing complication

- post traumatic degenerative joint disease (DJD) with hardware

- revision surgery

- inflammatory arthritis

- anticoagulation outside of the standard of care.
We found this trial at
1
site
New York University School of Medicine
550 1st Ave
New York, New York 10016
(212) 263-7300
Principal Investigator: William Long, MD
Phone: 212-598-6146
New York University School of Medicine NYU School of Medicine has a proud history that...
?
mi
from
New York, NY
Click here to add this to my saved trials